Diseases, Conditions, Syndromes

Study suggests Delta does not cause more severe childhood COVID

US pediatric COVID hospitalizations have surged since Delta became predominant, but a new study that offers a first look at the relevant data suggests that fears the variant causes more severe disease are unfounded.

Vaccination

Glaxo, SK bioscience start final trial of COVID jab

British drugs giant GlaxoSmithKline and South Korean peer SK bioscience have begun final stage trials of a COVID-19 jab after positive early results, they announced Tuesday.

Cardiology

Flu jab after heart attack should become standard care

Influenza vaccination reduces the risk of all-cause death, myocardial infarction, or stent thrombosis at 12 months in hospitalized patients with myocardial infarction or high-risk coronary disease, according to late breaking ...

Medical research

Largest real-world study of COVID-19 vaccine safety published

The Clalit Research Institute, in collaboration with researchers from Harvard University, analyzed one of the world's largest integrated health record databases to examine the safety of the Pfizer/BioNTech BNT162B2 vaccine ...

page 26 from 40